Prediction: Lilly Will Reach $1,200 in 2026 — Investment Thesis
Eli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...
A quick guide helps you compare 401(k) options for your 30s, focusing on fees, employer matches, and potential tax outcomes.
24,631 articlesEli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...
A top investor argues the vast US financial economy is due for a shift into the physical economy, centered on metals ...
The USHY high-yield ETF nears a pivotal 350 basis-point spread threshold, a move that could overshadow a year of coup...
CoreWeave trades around $100 as a massive backlog tests cash-generation prospects. Q1 results show strong revenue gro...
Kalshi and Polymarket have launched a coordinated policy crackdown on paid influencers promoting election fraud claim...
Bitcoin remains range-bound as a surge in AI-related spending draws liquidity away from crypto, according to Arthur H...
The CLARITY Act fight over crypto ethics stalled as lawmakers clashed on enforcement and state powers, leaving invest...
New CPI data renews tensions between Trump’s White House and Fed Chair Warsh, signaling a potential policy clash as i...
Dell Technologies pivots from PC maker to AI infrastructure leader, as it visits higher backlog levels and raises rev...
May PPI rose 6.5% year over year, signaling headline inflation pressure at wholesale levels. Yet a steady core measur...
Forgotten DeFi contracts lingering on-chain pose a fresh risk. The next defi drain could hinge on legacy pools and re...
SpaceX is marching toward a potential public listing with heavy investor interest. This piece analyzes the factors th...